作者:
El-Jawahri,A. [1]
;
Pidala,J. [2]
;
Inamoto,Y. [3]
;
Chai,X. [4]
;
Khera,N. [5]
;
Wood,W.A. [6]
;
Cutler,C. [7]
;
Arora,M. [8]
;
Carpenter,P.A. [9]
;
Palmer,J. [10]
;
Flowers,M. [11]
;
Weisdorf,D. ;
Pavletic,S. ;
Jaglowski,S. ;
Jagasia,M. ;
Lee,S.J. ;
Chen,Y.-B.
作者单位:
Division of Hematology-Oncology, Ohio State University Medical Center, Columbus, OH, United States
[1]
Hematology and Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN
[2]
Division of Bone Marrow Transplantation, Massachusetts General Hospital Cancer Center, Boston, MA
[3]
Linenberger Comprehensive Cancer Center, University of North Carolina Hospitals, Chapel Hill, NC
[4]
Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
[5]
Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, United States
[6]
Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, United States
[7]
Division of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI, United States
[8]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[9]
Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA, United States
[10]
National Cancer Institute, National Institutes of Health Center for Cancer Research, Bethesda, MD
[11]
发布时间
2015-02-03